Abstract
A series of styrylquinolines and quinolineamides based on the 8-hydroxyquinoline moiety were investigated as potential antimycobacterial agents. The lipophilicity of the compounds was measured using RP-HPLC and the tests of their activity against Mycobacterium kansasii, the M. avium complex, M. smegmatis, M. abscessus, M. tuberculosis and M. avium paratuberculosis was performed. Several of the compounds that were obtained appeared to be more effective than isoniazid and ciprofloxacin. The 5,7-dinitro-8-hydroxyquinoline derivative possessed the highest potency against M. abscessus and M. Smegmatis, which was about twice as effective as ciprofloxacin, while 2-(2-hydroxystyryl)-8-hydroxyquinoline-7-carboxylic acid appeared to be comparable with the standard drugs that are against the M. avium complex. The structure activity relationships are discussed.
Keywords: Cytotoxicity, drug design, lipophilicity, mycobacterium, quinoline derivatives, styrylquinolines.
Graphical Abstract
Medicinal Chemistry
Title:Investigation of the Antimycobacterial Activity of 8-hydroxyquinolones
Volume: 11 Issue: 8
Author(s): Wioleta Cieslik, Ewelina Spaczynska, Katarzyna Malarz, Dominik Tabak, Eoghan Nevin, Jim O'Mahony, Aidan Coffey, Anna Mrozek-Wilczkiewicz, Josef Jampilek and Robert Musiol
Affiliation:
Keywords: Cytotoxicity, drug design, lipophilicity, mycobacterium, quinoline derivatives, styrylquinolines.
Abstract: A series of styrylquinolines and quinolineamides based on the 8-hydroxyquinoline moiety were investigated as potential antimycobacterial agents. The lipophilicity of the compounds was measured using RP-HPLC and the tests of their activity against Mycobacterium kansasii, the M. avium complex, M. smegmatis, M. abscessus, M. tuberculosis and M. avium paratuberculosis was performed. Several of the compounds that were obtained appeared to be more effective than isoniazid and ciprofloxacin. The 5,7-dinitro-8-hydroxyquinoline derivative possessed the highest potency against M. abscessus and M. Smegmatis, which was about twice as effective as ciprofloxacin, while 2-(2-hydroxystyryl)-8-hydroxyquinoline-7-carboxylic acid appeared to be comparable with the standard drugs that are against the M. avium complex. The structure activity relationships are discussed.
Export Options
About this article
Cite this article as:
Cieslik Wioleta, Spaczynska Ewelina, Malarz Katarzyna, Tabak Dominik, Nevin Eoghan, O'Mahony Jim, Coffey Aidan, Mrozek-Wilczkiewicz Anna, Jampilek Josef and Musiol Robert, Investigation of the Antimycobacterial Activity of 8-hydroxyquinolones, Medicinal Chemistry 2015; 11 (8) . https://dx.doi.org/10.2174/1573406410666150807111703
DOI https://dx.doi.org/10.2174/1573406410666150807111703 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Bioactive Secondary Metabolites from Endophytic Fungi
Current Medicinal Chemistry Current Study of the Detection and Treatment Targets of Spinal Tuberculosis
Current Drug Targets Recent Progress in Biological Activities of Indole and Indole Alkaloids
Mini-Reviews in Medicinal Chemistry Bacterial Urease and its Role in Long-Lasting Human Diseases
Current Protein & Peptide Science New Approaches to Drug-DNA Interactions Based on Graphical Representation and Numerical Characterization of DNA Sequences
Current Computer-Aided Drug Design 3-Phenyl-1H-Indole-5-Sulfonamides: Structure-Based Drug Design of a Promising Class of Carbonic Anhydrase Inhibitors
Current Pharmaceutical Design Patents Review in siRNA Delivery for Pulmonary Disorders
Recent Patents on Drug Delivery & Formulation Microbial Metabolomics
Current Genomics Marine Microbes-Derived Anti-Bacterial Agents
Mini-Reviews in Medicinal Chemistry Recent Advances in Medicinal Chemistry to Treat Tuberculosis – Part-II
Current Topics in Medicinal Chemistry In Vitro Drug-Drug Interaction Potential of Sulfoxide and/or Sulfone Metabolites of Albendazole, Triclabendazole , Aldicarb, Methiocarb, Montelukast and Ziprasidone
Drug Metabolism Letters Advances in Mycobacterial Isocitrate Lyase Targeting and Inhibitors
Current Medicinal Chemistry New and Old Hot Drug Targets in Tuberculosis
Current Medicinal Chemistry FtsZ: A Novel Target for Tuberculosis Drug Discovery
Current Topics in Medicinal Chemistry One-Step Synthesis of 1H-1,2,3-Triazol-1-Ylmethyl-2,3-Dihydronaphtho[1,2-b]furan- 4,5-Diones
Current Organic Synthesis P-Glycoprotein - Implications of Metabolism of Neoplastic Cells and Cancer Therapy
Current Cancer Drug Targets Multi-Target QSAR Approaches for Modeling Protein Inhibitors. Simultaneous Prediction of Activities Against Biomacromolecules Present in Gram-Negative Bacteria
Current Topics in Medicinal Chemistry Resveratrol Targets in Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Impurity Profiling-A Significant Approach in Pharmaceuticals
Current Pharmaceutical Analysis Substrate Spectra of Nucleoside Phosphorylases and their Potential in the Production of Pharmaceutically Active Compounds
Current Pharmaceutical Design